Business/press release/2026-10-27

Live2.ai secures Rs 130 Crore ($13.7M) in Pre-Series B funding round

AI startup Live2.ai has successfully raised funding in a Pre-Series B round, with reports indicating the company secured Rs 130 Crore. This amount is also reported as $13.7 million across some outlets. The funding round was led by IvyCap Ventures, a detail confirmed by several publications. The capital is earmarked for expanding Live2.ai's AI-led social commerce platform, connecting social intelligence with commerce, and supporting its global scaling ambitions. The widespread reporting across nine different outlets suggests this information originated from a company announcement or press release.

9 articles from 9 outlets covered this story. No difference in framing or figures was found between them. The underlying claim is sourced from a press release.

What do all outlets agree on?

9 outlets covered “Live2.ai secures Rs 130 Crore ($13.7M) in Pre-Series B funding round”. All of them report the following:

  • Live2.ai raised funding
  • The funding round is Pre-Series B
  • Live2.ai is an AI startup
  • Live2.ai operates an AI-led social commerce platform

Did outlets disagree about this?

No. All 9 outlets covering “Live2.ai secures Rs 130 Crore ($13.7M) in Pre-Series B funding round” reported it the same way — no difference in framing or figures was found between them.

Which figures do outlets report differently?

1 figure in this story is reported with conflicting values:

Funding AmountRs 130 Cr vs Rs 130 Crore vs ₹130 crore vs Rs 130 cr vs ₹130 Cr vs $13.7M

Which outlets covered this?

All 9 articles found on this story, grouped by the stance of the piece. Every link goes to the original publisher.

What related stories are there?

Get the week in AI in one email

What happened, which outlets reported it, and where their coverage differed. One issue a week.

The first issue hasn’t gone out yet. Subscribe and it’s the one you’ll get.

We’ll send the digest and nothing else. One-click unsubscribe. Privacy.